Загрузка...
CD38‐Targeted Theranostics of Lymphoma with (89)Zr/(177)Lu‐Labeled Daratumumab
Lymphoma is a heterogeneous disease with varying clinical manifestations and outcomes. Many subtypes of lymphoma, such as Burkitt′s lymphoma and diffuse large B cell lymphoma, are highly aggressive with dismal prognosis even after conventional chemotherapy and radiotherapy. As such, exploring specif...
Сохранить в:
| Опубликовано в: : | Adv Sci (Weinh) |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8132161/ https://ncbi.nlm.nih.gov/pubmed/34026426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202001879 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|